Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development

PAGE 41 1 P01 A143042-01 16 SEP Ho, David D. The facilities, both in terms or space and equipment, are outstanding and appropriate. The budget, as written, can termned. Human Subjects: code 10 Gender and Minority Representation: not applicable Animal Welfare: code 30 Budget: As resented, the proposed budget is incomplete, lacks details, and therefore cannot be evaluated. IRG Action: This project, ived a priority score in the very good range with a numerical value o249. Administrative Note: The proposed budget for Project 2 is incomplete and lack details. It is recommended that the applicants submit a complete and detailed budget. PROJECT 3: Priming With Recombinant Vaccinia or DNA Vaccines followed by Boosting Hith Pseudovirions or Envelope Proteins Critique: The comments below represent essentially unedited comments from the reviewers of this application. They are included to indicate the range of comments made during the discussion, and may not reflect the final thinking of the committee. The RESUME and OVERALL CRITIQUE sections above summarize the final opinion of the committee after the discussion. REVIEHER A: Project 3 of this application is designed to deal with the optimization of humoral and cellular immune responses to HIV/SIV protein components in experimental animal models through a series of "prime-boost" experiments. The proposed priming immunizations will employ new vectors capable of intracellular expression of viral antigens and will induce T cellmediated immune responses, including CTL. Boosts will be performed with new variants of soluble HIV/SIV proteins and will stimulate B cells to produce neutralizing antibodies. Specific aims include construction of new delivery vectors based on recombinant vaccine viruses/pseudovirions and new DNA-vaccine plasmids, limited testing of immunogens, adjuvants, and liposomes in vitro and in small animal model (guinea pigs) and monkeys (macaques), and testing of the most promising priming and boosting combinations in the expanded experimental series involving macaques. This project, to be jointly supervised and executed by ADARC staff under the direction of Dr. D. Ho, draws on the enormous body of systematic and anecdotal knowledge accumulated by these researchers and by their collaborators and/or competitors over the period of a decade. As pointed out by the Principal Investigator, the design of the proposed studies is iterative. The laboratory-based research program will be Continued

/ 30

Actions

file_download Download Options Download this page PDF - Pages 1- Image - Page 16 Plain Text - Page 16

About this Item

Title
Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development
Author
Schultz, Alan M.
Canvas
Page 16
Publication
1998-01-12
Subject terms
proposals
Item type:
proposals

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0421.017
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0421.017/16

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0421.017

Cite this Item

Full citation
"Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0421.017. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel